Back Login for AI Analysis

    QNRX (STOCKS)

    Quoin Pharmaceuticals, Ltd. American Depositary Shares

    $4.600000
    +0.400000 (+9.52%)
    Prev close: $4.200000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Michael Myers
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $8.95M
    Employees
    3
    P/E (TTM)
    -0.02
    P/B (TTM)
    1.04
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Nonoperating Income/Loss $474.54K
    Selling, General, and Administrative Expenses $6.60M
    Research and Development $10.86M
    Income/Loss From Continuing Operations After Tax -$16.99M
    Income/Loss From Continuing Operations Before Tax -$16.99M
    Net Income/Loss -$16.99M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$16.99M
    Net Income/Loss Available To Common Stockholders, Basic -$16.99M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Assets $15.69M
    Current Assets $15.33M
    Noncurrent Assets $358.33K
    Intangible Assets $358.33K
    Liabilities $6.92M
    Current Liabilities $5.35M
    Accounts Payable $1.78M
    Other Current Liabilities $3.57M
    Noncurrent Liabilities $1.57M
    Equity $8.77M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $8.77M
    Liabilities And Equity $15.69M
    Net Cash Flow From Operating Activities -$15.82M
    Net Cash Flow From Operating Activities, Continuing -$15.82M
    Net Cash Flow From Investing Activities -$2.93M
    Net Cash Flow From Investing Activities, Continuing -$2.93M
    Net Cash Flow From Financing Activities $18.05M
    Net Cash Flow From Financing Activities, Continuing $18.05M
    Net Cash Flow -$697.44K
    Net Cash Flow, Continuing -$697.44K
    Comprehensive Income/Loss -$16.99M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$16.99M
    Other Comprehensive Income/Loss -$159.00